Skip to main navigation
Close
Main navigation
Advocacy
Issue Overview
Sustainable Supply Chain
Biosimilars
IP & Patent Reform
Medicaid Generics Penalty
State Legislation
Trade
Events
Our Impact
About Us
Generic Quality
About the Association
Our Team
Our Members
Meet Our Board
Social Commitment
Generic Medicines
Biosimilars
Careers
Contact Us
Resources
Search Resources
2020 Access and Savings Report
Supply Chain Blueprint
Industry Response to COVID-19
Press Releases
Blog
State Lawmaker Toolkit
Amicus Briefs
Join
Take Action
Menu
In the News
- AAM CEO Dan Leonard shares the industry's 2021 outlook with Chain Drug Review.
Learn More
Close
Breadcrumb
Home
Resources
Press Releases
Press Releases
Share
Press Release
Jan 21, 2021
| Rachel Schwartz
AAM Statement on Biden’s Executive Orders to Strengthen America’s COVID Response
Press Release
Jan 15, 2021
| Rachel Schwartz
AAM and Biosimilars Council Statement on CMS Decision to Update Part D Program
Press Release
Dec 10, 2020
| Rachel Schwartz
AAM Statement on President-elect Biden Naming Katherine Tai as U.S. Trade Representative
Press Release
Dec 7, 2020
| Rachel Schwartz
AAM Statement on President-elect Biden Naming Xavier Becerra as Secretary of Health and Human Services
Press Release
Nov 20, 2020
| Rachel Schwartz
AAM Statement on Trump’s Drug Pricing Ruling – Rebates and Most Favored Nation Model
Press Release
Nov 11, 2020
| Rachel Schwartz
AAM Statement on 2020 Election
Press Release
Oct 7, 2020
| Rachel Schwartz
AAM Statement on the Introduction of the Protecting Access to Affordable Medicines Act of 2020
Press Release
Sep 29, 2020
| Rachel Schwartz
AAM Releases 12th Annual Access & Savings Report
Press Release
Aug 25, 2020
| Rachel Schwartz
Association for Accessible Medicines Names New President and CEO
Press Release
Aug 10, 2020
| Rachel Schwartz
Lisa Steelman Joins AAM as Vice President, State Government Affairs
Press Release
Aug 6, 2020
| Rachel Schwartz
Generic and Biosimilar Industry Statement on Essential Medicines Executive Order
Press Release
Jul 2, 2020
| Rachel Schwartz
AAM Commends Introduction of the Increasing Access to Biosimilars Act
Load More
Advocacy
Issue Overview
Sustainable Supply Chain
Biosimilars
IP & Patent Reform
Medicaid Generics Penalty
State Legislation
Trade
Events
GRx+Biosims 2020
Our Impact
About Us
Generic Quality
About the Association
Our Team
Our Members
Meet Our Board
Social Commitment
Generic Medicines
Biosimilars
Careers
Contact Us
Resources
Search Resources
2020 Access and Savings Report
Supply Chain Blueprint
Industry Response to COVID-19
Press Releases
Blog
State Lawmaker Toolkit
Amicus Briefs
Join
Take Action